Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods

Mutation Research - Reviews in Mutation Research

Volumn 543, Issue 1, 2003, Pages 17-30

  Boysen, Gunnar ^a   Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Benzo a pyrene; DNA adducts; Polycyclic aromatic hydrocarbons; Protein adducts; Structure specific methods

Indexed keywords

ALCOHOL DERIVATIVE; BENZO[A]PYRENE; BENZO[A]PYRENE DERIVATIVE; CARCINOGEN; DIHYDROXYEPOXY 7,8,9,10 TETRAHYDROBENZO[A]PYRENE; DNA; PHOSPHORUS 32; PROTEIN; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; CIGARETTE SMOKING; CONTROLLED STUDY; DNA ADDUCT; DNA DETERMINATION; DNA POLYMORPHISM; DNA STRUCTURE; ENVIRONMENTAL EXPOSURE; FLUORESCENCE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYDROLYSIS; IMMUNOASSAY; INTERMETHOD COMPARISON; ISOTOPE LABELING; MASS SPECTROMETRY; METABOLISM; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; STRUCTURE ANALYSIS;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; BENZO(A)PYRENE; CARCINOGENS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA; DNA ADDUCTS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MOLECULAR STRUCTURE; PROTEINS;

EID: 0037219083     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(02)00068-6     Document Type: Review

References (80)

1. Phillips D.H. Fifty years of benzo[a]pyrene. Nature. 303:1983;468-472.
2. Polynuclear aromatic compounds. Part 1. Chemical, environmental and experimental data, in: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 32, International Agency for Research on Cancer (IARC), Lyon, FR, 1983, pp. 33-91.
3. Polynuclear aromatic compounds. Part 3. Industrial exposures in aluminum production, coal gasification, coke production, and iron and steel founding, in: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 34, International Agency for Research on Cancer (IARC), Lyon, FR, 1984, pp. 65-131.
4. Certain polycyclic aromatic hydrocarbons and heterocyclic compounds, in: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, vol. 3, International Agency for Research on Cancer (IARC), Lyon, FR, 1973, pp. 91-136.
5. A. Dipple, R.C. Moschel, C.A.H. Bigger, Polynuclear aromatic hydrocarbons, in: C.E. Searcle (Ed.), Chemical Carcinogens, vol. 182, American Chemical Society, Washington, DC, 1984, pp. 41-163.
6. Gelboin H.V. Benzo[a]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed function oxides and related enzymes. Physiol. Rev. 60:1980;1107-1166.
7. Cooper C.S., Grover P.L., Sims P. The metabolism and activation of benzo[a]pyrene. Prog. Drug Metab. 7:1983;295-396.
8. Pelkonen O., Nebert D.W. Metabolism of polycyclic hydrocarbons: etiologic role in carcinogenesis. Pharmacol. Rev. 34:1982;189-222.
9. Conney A.H., Chang R.L., Jerina D.M., Wei S.J.C. Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. Drug Metab. Rev. 26:1994;125-163.
10. E.L. Cavalieri, E.G. Rogan, One-electron oxidation in aromatic hydrocarbon carcinogenesis, in: R.G. Harvey (Ed.), Polycyclic Hydrocarbons and Carcinogenesis, American Chemical Society, 1985, pp. 289-305.
11. D.R. Thakker, H. Yagi, W. Levin, A.W. Wood, A.H. Conney, D.M. Jerina, Polycyclic aromatic hydrocarbons: metabolic activation to ultimate carcinogens, in: M.W. Anders (Ed.), Bioactivation of Foreign Compounds, Academic Press, New York, 1985, pp. 177-242.
12. Conney A.H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Res. 42:1982;4875-4917.
13. W.M. Baird, S.L. Ralston, Carcinogenic polycyclic aromatic hydrocarbons, in: G.T. Bowden, S.M. Fischer (Eds.), Comprehensive Toxicology: Chemical Carcinogens and Anticarcinogens, vol. 12, Elsevier, New York, 1997, pp. 171-200.
14. Geacintov N.E., Cosman M., Hingerty B.E., Amin S., Broyde S., Patel D.J. NMR solution structures of stereoisomeric covalent polycyclic aromatic carcinogen-DNA adducts: principles, patterns, and diversity. Chem. Res. Toxicol. 10:1997;112-146.
15. 2-dG adduct of (+)-anti-B[a]PDE shows a dramatically different mutagenic specificity (predominantly, G → A) in a 5′-CGT-3′ sequence context. Biochemistry. 36:1997;10256-10261.
16. 2-dG) in the eight conformations and the five DNA sequences most relevant to base substitution mutagenesis. Carcinogenesis. 20:1999;85-94.
17. Melendez-Colon V.J., Luch A., Seidel A., Baird W.M. Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites. Carcinogenesis. 20:1999;1885-1891.
18. Kriek E., Rojas M., Alexandrov K., Bartsch H. Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. Mutat. Res. 400:1998;215-231.
19. Angerer J., Mannschreck C., Gundel J. Biological monitoring and biochemical effect monitoring of exposure to polycyclic aromatic hydrocarbons. Int. Arch. Occup. Environ. Health. 70:1997;365-377.
20. Phillips D.H. DNA adducts in human tissues: biomarkers of exposure to carcinogens in tobacco smoke. Environ. Health Perspect. 104(Suppl. 5):1996;453-458.
21. Poirier M.C., Santella R.M., Weston A. Carcinogen macromolecular adducts and their measurement. Carcinogenesis. 21:2000;353-359.
22. Kaderlik K.R., Kadlubar F.F. Metabolic polymorphisms and carcinogen-DNA adduct formation in human populations. Pharmacogenetics. 5:1995;S108-S117.
23. Santella R. Immunological methods for detection of carcinogen-DNA damage in humans. Cancer Epidemiol. Biomarkers Prev. 8:1999;733-739.
24. Skipper P.L., Peng X., SooHoo C.K., Tannenbaum S.R. Protein adducts as biomarkers of human carcinogen exposure. Drug Metab. Rev. 26:1994;111-124.
25. Castelao J.E., Yuan J.M., Skipper P.L., Tannenbaum S.R., Gago-Dominguez M., Crowder J.S., Ross R.K., Yu M.C. Gender- and smoking-related bladder cancer risk. J. Natl. Cancer Inst. 93:2001;538-545.
26. Phillips D.H., Farmer P.B., Beland F.A., Nath R.G., Poirier M.C., Reddy M.V., Turteltaub K.W. Methods of DNA adduct determination and their application to testing compounds for genotoxicity. Environ. Mol. Mutagen. 35:2000;222-233.
27. 32P -Postlabeling for the detection of DNA adducts, in: G.P. Pfeifer (Ed.), Technologies for the Detection of DNA Damage and Mutation, Plenum Press, New York, 1996, pp. 45-61.
28. Shields P.G., Bowman E.D., Harrington A.M., Doan V.T., Weston A. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res. 53:1993;3486-3492.
29. van Schooten F.J., Hillelbrand M.J.X., van Leeuwen F.E., van Zandwijk N., Jansen H.M., Den Engelse L., Kriek E. Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells from lung cancer patients: no correlation with adduct levels in lung. Carcinogenesis. 13:1992;987-993.
30. 32P -postlabeling and ELISA Carcinogenesis. 15:1994;557-560.
31. Rojas M., Godschalk R., Alexandrov K., Cascorbi I., Kriek E., Ostertag J., van Schooten F.J., Bartsch H. Myeloperoxidase-463A variant reduces benzo[α]pyrene diol epoxide-DNA adducts in skin of coal tar treated patients. Carcinogenesis. 22:2001;1015-1018.
32. Vahakangas K., Haugen A., Harris C.C. An applied synchronous fluorescence spectrophotometric assay to study benzo[a]pyrene-diol epoxide-DNA adducts. Carcinogenesis. 6:1985;1109-1116.
33. Harris C.C., Vahakangas K., Newman M.J., Trivers G.E., Shamsuddin A., Sinopoli N., Mann D.L., Wright W.E. Detection of benzo[a]pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. Proc. Natl. Acad. Sci. U.S.A. 82:1985;6672-6676.
34. Weston A., Rowe M.L., Manchester D.K., Farmer P.B., Mann D.L., Harris C.C. Fluorescence and mass-spectral evidence for the formation of benzo[a]pyrene anti-diol epoxide-DNA and -hemoglobin adducts in humans. Carcinogenesis. 10:1989;251-257.
35. 32P -postlabeling analysis of human placental DNA known to contain benzo[a]pyrene diol epoxide adducts Carcinogenesis. 11:1990;553-559.
36. Weston A., Manchester D.K., Poirier M.C., Choi J.S., Trivers G.E., Mann D.L., Harris C.C. Derivative fluorescence spectral analysis of polycyclic aromatic hydrocarbon-DNA adducts in human placenta. Chem. Res. Toxicol. 2:1989;104-108.
37. Manchester D.K., Weston A., Choi J.S., Trivers G.E., Fennessey P.V., Quintana E., Farmer P.B., Mann D.L., Harris C.C. Detection of benzo[a]pyrene diol epoxide-DNA adducts in human placenta. Proc. Natl. Acad. Sci. U.S.A. 85:1988;9243-9247.
38. 32P -labelling analysis of PAH-DNA adducts in human lung and the relationship to TP53 mutations Mutat. Res. 368:1996;275-282.
39. Alexandrov K., Rojas M., Geneste O., Castegnaro M., Camus A.M., Petruzzelli S., Giuntini C., Bartsch H. An improved fluorometric assay for dosimetry of benzo[a]pyrene diol epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Res. 52:1992;6248-6253.
40. Pastorelli R., Restano J., Guanci M., Maramonte M., Magagnotti C., Allevi R., Lauri D., Fanelli R., Airoldi L. Hemoglobin adducts of benzo[a]pyrene diol epoxide in newspaper vendors: association with traffic exhaust. Carcinogenesis. 17:1996;2389-2394.
41. Melikian A.A., Sun P., Pierpont C., Coleman S., Hecht S.S. Gas chromatography-mass spectrometric determination of benzo[a]pyrene and chrysene diol epoxide globin adducts in humans. Cancer Epidemiol. Biomarkers Prev. 6:1997;833-839.
42. Weston A., Bowman E. Fluorescence detection of benzo[a]pyrene-DNA adducts in human lung. Carcinogenesis. 12:1991;1445-1449.
43. Pastorelli R., Guanci M., Cerri A., Negri E., La Vecchia C., Fumagalli F., Mezzetti M., Cappelli R., Panigalli T., Fanelli R., Airoldi L. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome 450 enzymes on DNA, and blood protein adducts of benzo[a]pyrene-diol epoxide. Cancer Epidemiol. Biomarkers Prev. 7:1998;703-709.
44. Rojas M., Cascorbi I., Alexandrov K., Kriek E., Auburtin G., Mayer L., Kopp-Schneider A., Roots I., Bartsch H. Modulation of benzo[a]pyrene diol epoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1, and GSTT1 polymorphisms. Carcinogenesis. 21:2000;35-41.
45. Pavanello S., Favretto D., Brugnone F., Mastrangelo G., Dal Pra G., Clonfero E. HPLC/fluorescence determination of anti-BPDE-DNA adducts in mononuclear white blood cells from PAH-exposed humans. Carcinogenesis. 20:1999;431-435.
46. Pavanello S., Gabbani G., Mastrangelo G., Brugnone F., Maccacaro G., Clonfero E. Influence of GSTM1 genotypes on anti-BPDE-DNA adduct levels in mononuclear white blood cells of humans exposed to PAH. Int. Arch. Occup. Environ. Health. 72:1999;238-246.
47. Casale G.P., Singhal M., Bhattacharya S., Ramanathan R., Roberts K.P., Barbacci D.C., Zhao J., Jankowiak R., Gross M.L., Cavalieri E.L., Small G.J., Rennard S.I., Mumford J.L., Shen M. Detection and quantification of depurinated benzo[a]pyrene-adducted DNA bases in the urine of cigarette smokers and women exposed to household coal smoke. Chem. Res. Toxicol. 14:2001;192-201.
48. Roberts K.P., Lin C.H., Singhal M., Casale G.P., Small G.J., Jankowiak R. On-line identification of depurinating DNA adducts in human urine by capillary electrophoresis-fluorescence line narrowing spectroscopy. Electrophoresis. 21:2000;799-806.
49. Skipper P.L., Naylor S., Gan L.S., Day B.W., Pastorelli R., Tannenbaum S.R. Origin of tetrahydrotetrols derived from human hemoglobin adducts of benzo[a]pyrene. Chem. Res. Toxicol. 2:1989;280-281.
50. Naylor S., Gan L.S., Day B.W., Pastorelli R., Skipper P.L., Tannenbaum S.R. Benzo[a]pyrene diol epoxide adduct formation in mouse and human hemoglobin: physicochemical basis for dosimetry. Chem. Res. Toxicol. 3:1990;111-117.
51. Day B.W., Naylor S., Gan L.S., Sahali Y., Nguyen T.T., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Molecular dosimetry of polycyclic aromatic hydrocarbon epoxides and diol epoxides via hemoglobin adducts. Cancer Res. 50:1990;4611-4618.
52. Day B.W., Naylor S., Gan L.S., Sahali Y., Nguyen T.T., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Gas chromatographic-mass spectrometric analysis of diols and tetrols from reactions of polycyclic aromatic hydrocarbon epoxides with hemoglobin. J. Chromatogr. B. 562:1991;563-571.
53. Day B.W., Skipper P.L., Rich R.H., Naylor S., Tannenbaum S.R. Conversion of a hemoglobin α-chain aspartate (47) ester to N-(2,3-dihydroxypropyl)asparagine as a method for identification of the principal binding site for benzo[a]pyrene anti-diol epoxide. Chem. Res. Toxicol. 4:1991;359-363.
54. 146. J. Am. Chem. Soc. 113:1991;8505-8509.
55. Brunmark P., Harriman S., Skipper P., Wishnok J., Amin S., Tannenbaum S. Identification of subdomain IB in human serum albumin as a major binding site for polycyclic aromatic hydrocarbon epoxides. Chem. Res. Toxicol. 10:1997;880-886.
56. Day B.W., Skipper P.L., Zaia J., Singh K., Tannenbaum S.R. Enantiospecificity of covalent adduct formation by benzo[a]pyrene anti-diol epoxide with human serum albumin. Chem. Res. Toxicol. 7:1994;829-835.
57. Ozbal C.C., Skipper P.L., Yu M.C., London S.J., Dasari R.R., Tannenbaum S.R. Quantification of (7S,8R)-dihydroxy-(9R,10S)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene adducts in human serum albumin by laser-induced fluorescence: implications for the in vivo metabolism of benzo[a]pyrene. Cancer Epidemiol. Biomarkers Prev. 9:2000;733-739.
58. Frank S., Renner T., Ruppert T., Scherer G. Determination of albumin adducts of (+)-anti-benzo[a]pyrene-diol epoxide using an high performance liquid chromatographic column switching technique for sample preparation and gas chromatography-mass spectrometry for the final detection. J. Chromatogr. B. 713:1998;331-337.
59. Scherer G., Frank S., Riedel K., Merger-Kossien I., Renner T. Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons. Cancer Epidemiol. Biomarkers Prev. 9:2000;373-380.
60. Pastorelli R., Guanci M., Restano J., Berri A., Micoli G., Minoia C., Alcini D., Carrer P., Negri E., La Vecchia C., Fanelli R., Airoldi L. Seasonal effect on airborne pyrene, urinary 1-hydroxypyrene, and benzo[a]pyrene diol epoxide-hemoglobin adducts in the general population. Cancer Epidemiol. Biomarkers Prev. 8:1999;561-565.
61. Jacob J., Grimmer G., Hildebrandt A. Trends in environmental pollution by PAH in Germany during the period 1985-1995. Polycyclic Aromat. Compd. 9:1996;143-149.
62. Perera F.P., Dickey C., Santella R., O'Neill J.P., Albertini R.J., Ottman R., Tsai W.Y., Mooney L.A., Savela K., Hemminki K. Carcinogen-DNA adducts and gene mutation in foundry workers with low-level exposure to polycyclic aromatic hydrocarbons. Carcinogenesis. 15:1994;2905-2910.
63. 32P -postlabeling and enzyme-linked immunosorbent assay Environ. Health Perspect. 99:1993;307-309.
64. Chepiga T.A., Morton M.J., Murphy P.A., Avalos J.T., Bombick B.R., Doolittle D.J., Borgerding M.F., Swauger J.E. A comparison of the mainstream smoke chemistry and mutagenicity of a representative sample of the US cigarette market with two Kentucky reference cigarettes (K1R4F and K1R5F). Food Chem. Toxicol. 38:2000;949-962.
65. Tobacco smoking, in: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 38, International Agency for Research on Cancer (IARC), Lyon, FR, 1986, pp. 111-114.
66. Stowers S.J., Anderson M.W. Formation and persistence of benzo[a]pyrene metabolite-DNA adducts. Environ. Health Perspect. 62:1985;31-39.
67. Grimmer G., Dettbarn G., Jacob J. Biomonitoring of polycyclic aromatic hydrocarbons in highly exposed coke plant workers by measurement of urinary phenanthrene and pyrene metabolites (phenols and dihydrodiols). Int. Arch. Occup. Environ. Health. 65:1993;189-199.
68. Hecht S.S. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis. 23:2002;907-922.
69. Waldman J.M., Lioy P.J., Greenberg A., Butler J.P. Analysis of human exposure to benzo[a]pyrene via inhalation and food ingestion in the total human environmental exposure study (THEES). J. Exp. Anal. Environ. Epidemiol. 1:1991;193-225.
70. Pastorelli R., Cerri A., Mezzetti M., Consonni E., Airoldi L. Effect of DNA repair gene polymorphisms on BPDE-DNA adducts in human lymphocytes. Int. J. Cancer. 100:2002;9-13.
71. Rojas M., Alexandrov K., Cascorbi I., Brockmoller J., Likhachev A., Pozharisski K., Bouvier G., Auburtin G., Mayer L., Koop-Schneider A., Roots I., Bartsch H. High benzo[a]pyrene diol epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/MspI-GSTM1 *0/*0 genotypes. Pharmacogenetics. 8:1998;109-118.
72. Lodovici M., Akpan V., Giovannini L., Migliani F., Dolara P. Benzo[a]pyrene diol epoxide DNA adducts and levels of polycyclic aromatic hydrocarbons in autoptic samples from human lungs. Chem. Biol. Interact. 116:1998;199-212.
73. Melikian A.A., Sun P., Prokopczyk B., El Bayoumy K., Hoffmann D., Wang X., Waggoner S. Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry. Cancer Lett. 146:1999;127-134.
74. Izzotti A., De Flora S., Petrilli G.L., Gallagher J., Rojas M., Alexandrov K., Bartsch H., Lewtas J. Cancer biomarkers in human atherosclerotic lesions: detection of DNA adducts. Cancer Epidemiol. Biomarkers Prev. 4:1995;105-110.
75. Alexandrov K., Rojas M., Kadlubar F.F., Lang N.P., Bartsch H. Evidence of anti-benzo[a]pyrene diol epoxide-DNA adduct formation in human colon mucosa. Carcinogenesis. 17:1996;2081-2083.
76. Rojas M., Alexandrov K., Auburtin G., Wastiaux-Denamur A., Mayer L., Mahieu B., Sebastien P., Bartsch H. Anti-benzo[a]pyrene diol epoxide-DNA adduct levels in peripheral mononuclear cells from coke oven workers and the enhancing effect of smoking. Carcinogenesis. 16:1995;1373-1376.
77. Ferreira M. Jr., Tas S., dell'Omo M., Goormans G., Buchet J.P., Lauwerys R. Determinants of benzo[a]pyrenediol epoxide adducts to haemoglobin in workers exposed to polycyclic aromatic hydrocarbons. Occup. Environ. Med. 51:1994;451-455.
78. Tas S., Buchet J.P., Lauwerys R. Determinants of benzo[a]pyrene diol epoxide adducts to albumin in workers exposed to polycyclic aromatic hydrocarbons. Int. Arch. Occup. Environ. Health. 66:1994;343-348.
79. Melikian A.A., Malpure S., John A., Meng M., Shoket B., Mayer G., Vincze I., Kolozsi-Ringelhamm A., Hecht S.S. Determination of hemoglobin and serum albumin adducts of benzo[a]pyrene by gas chromatography-mass spectrometry in humans and their relationship with exposure and to other biological markers. Polycyclic Aromat. Compd. 17:2000;125-134.
80. Pastorelli R., Guanci M., Cerri A., Minoia C., Carrer P., Negri E., Fanelli R., Airoldi L. Benzo[a]pyrene diol epoxide-haemoglobin and albumin adducts at low levels of benzo[a]pyrene exposure. Biomarkers. 5:2000;245-251.